Squarepoint Ops LLC Anixa Biosciences Inc Call Options Transaction History
Squarepoint Ops LLC
- $93.7 Billion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ANIX
# of Institutions
70Shares Held
5.33MCall Options Held
14.1KPut Options Held
12.1K-
Vanguard Group Inc Valley Forge, PA1.39MShares$5.74 Million0.0% of portfolio
-
Laird Norton Trust Company, LLC617KShares$2.54 Million0.28% of portfolio
-
D.A. Davidson & Co.614KShares$2.53 Million0.01% of portfolio
-
Ubs Group Ag505KShares$2.08 Million0.0% of portfolio
-
Mission Wealth Management, LP370KShares$1.52 Million0.03% of portfolio
About Anixa Biosciences Inc
- Ticker ANIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,661,700
- Market Cap $126M
- Description
- Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the...